Telehealth Companies Prescribing Unapproved GLP-1s for Addiction; CDC Criticized for Ignoring State Requests for Measles Test Aid

Telehealth companies are reportedly prescribing GLP-1 drugs for addiction without FDA approval for this indication, with some online platforms marketing these medications for substance use disorders while clinical trials are ongoing. This raises patient safety and regulatory concerns. Separately, the Centers for Disease Control and Prevention (CDC) is facing criticism for reportedly ignoring requests from California and Washington state health officials in May to validate a new measles test that could diagnose 500 cases in eight hours, delaying their response for two months amidst measles outbreaks.